356
Participants
Start Date
January 17, 2017
Primary Completion Date
February 1, 2020
Study Completion Date
April 2, 2024
Decipher Prostate Cancer Classifier
The Decipher test (GenomeDx Biosciences, San Diego, CA) is a genomic test that predicts high grade disease, the probability of metastasis and prostate cancer-specific mortality for men with prostate cancer.
Comprehensive Medical Center, PLLC, Royal Oak
Michigan Institute of Urology-Town Center, Troy
University of Michigan Hospital and Health Systems, Ann Arbor
IHA Urology at St. Joe's Ann Arbor, Ypsilanti
Wayne State University/Karmanos Cancer Institute, Detroit
Henry Ford Hospital, Detroit
Tri-City Urology, Saginaw
Urologic Consultants, Grand Rapids
Urology Associates of Grand Rapids, Grand Rapids
Michigan Urological Clinic, Grand Rapids
Spectrum Health Medical Group- Urology, Grand Rapids
Urology Surgeons, PC, Grand Rapids
Bay Area Urology Associates, PC, Traverse City
Collaborators (1)
Michigan Urological Surgery Improvement Collaborative (MUSIC)
OTHER
GenomeDx Biosciences Corp
INDUSTRY
University of Michigan Rogel Cancer Center
OTHER